Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03070483Phase 2Completed
Phase 2, open-label, single-arm trial of vitamin d in hypertension (HTN) and Vitamin D deficiency (VDD), sponsored by Loyola University Chicago. Primary endpoint: Mean Blood Pressure at 12 weeks. Started Mar 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03070483.